Literature DB >> 16566861

Cytokine and anti-cytokine therapy for asthma.

Hans-Uwe Simon1.   

Abstract

Cytokines play a critical role in the pathogenesis of asthma. Asthma resolution may depend on the correction of dysregulated cytokine expression, which is a characteristic feature of this chronic inflammatory disease. It is, therefore, not surprising that attempts have been made to either block cytokines present at elevated levels or to substitute cytokines that are insufficiently expressed in asthma. In this article, the results of these studies are discussed, and the obtained insights regarding asthma pathogenesis and new treatment options are summarized.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16566861     DOI: 10.1007/s11882-006-0049-9

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  56 in total

1.  Treatment with IFN-alpha in corticosteroid-unresponsive asthma.

Authors:  S Gratzl; A Palca; M Schmitz; H U Simon
Journal:  J Allergy Clin Immunol       Date:  2000-05       Impact factor: 10.793

2.  IL-10: a key regulator of allergic disease.

Authors:  P J Barnes
Journal:  Clin Exp Allergy       Date:  2001-05       Impact factor: 5.018

3.  Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis.

Authors:  Sabine-Gisela Plötz; Hans-Uwe Simon; Ulf Darsow; Dagmar Simon; Ekatherina Vassina; Shida Yousefi; Rüdiger Hein; Tim Smith; Heidrun Behrendt; Johannes Ring
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

Review 4.  T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases.

Authors:  Mübeccel Akdis; Kurt Blaser; Cezmi A Akdis
Journal:  J Allergy Clin Immunol       Date:  2005-10-10       Impact factor: 10.793

5.  The effects of nebulized recombinant interferon-gamma in asthmatic airways.

Authors:  M Boguniewicz; R J Martin; D Martin; U Gibson; A Celniker; M Williams; D Y Leung
Journal:  J Allergy Clin Immunol       Date:  1995-01       Impact factor: 10.793

6.  Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

Authors:  S A Bryan; B J O'Connor; S Matti; M J Leckie; V Kanabar; J Khan; S J Warrington; L Renzetti; A Rames; J A Bock; M J Boyce; T T Hansel; S T Holgate; P J Barnes
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

7.  Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma.

Authors:  T C van der Pouw Kraan; L C Boeije; E R de Groot; S O Stapel; A Snijders; M L Kapsenberg; J S van der Zee; L A Aarden
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

8.  Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

Authors:  N Mohan; E T Edwards; T R Cupps; P J Oliverio; G Sandberg; H Crayton; J R Richert; J N Siegel
Journal:  Arthritis Rheum       Date:  2001-12

Review 9.  Mechanisms of asthma.

Authors:  William W Busse; Lanny J Rosenwasser
Journal:  J Allergy Clin Immunol       Date:  2003-03       Impact factor: 10.793

10.  Clinical and immunological effects of low-dose IFN-alpha treatment in patients with corticosteroid-resistant asthma.

Authors:  H-U Simon; H Seelbach; R Ehmann; M Schmitz
Journal:  Allergy       Date:  2003-12       Impact factor: 13.146

View more
  1 in total

Review 1.  Steroid resistance in asthma: mechanisms and treatment options.

Authors:  Ian M Adcock; Paul A Ford; Pank Bhavsar; Tehireem Ahmad; Kian Fan Chung
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.